Search
Alvotech SA
ALVOAdd to Watchlist
4.120USD
+0.550+15.41%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.61BMarket Cap
42.76P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Alvotech SA is 7.33, ranking 296 out of 385 in the Biotechnology & Medical Research industry. The average price target is 9.75, with a high of 10.00 and a low of 5.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
6.500
Target Price
+57.77%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Alvotech SA
ALVO
5
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Alvotech SA's expected revenue for the next quarter?
Alvotech SA's expected revenue is 111.01M.
What is Alvotech SA's price target?
Analysts forecast that Alvotech SA's price target is USD 9.75, with the highest forecast at USD 10.00 and the lowest forecast at USD 5.00.
What is the analyst rating for Alvotech SA?
Based on the ratings of Alvotech SA's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.